The University of Chicago Header Logo

Christopher Daugherty

InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA087605     (DAUGHERTY, CHRISTOPHER K)Jul 1, 2000 - Apr 30, 2012
    Ethics and Clinical Trials in Advanced Cancer Care
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Roloff GW, Wen F, Ramsland A, Artz AS, Kosuri S, Stock W, Odenike O, Larson RA, Liu H, Godley LA, Thirman MJ, Patel AA, Daugherty CK, DuVall AS, Nawas MT, Dworkin E, Wool GD, Gurbuxani S, Fitzpatrick C, Segal JP, Wang P, Drazer MW. Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239. PMID: 36655425; PMCID: PMC10388285.
      Citations:    Fields:    Translation:Humans
    2. Hlubocky FJ, Daugherty CK, Peppercorn J, Young K, Wroblewski KE, Yamada SD, Lee NK. Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors. JCO Clin Cancer Inform. 2022 08; 6:e2200035. PMID: 35985004; PMCID: PMC9470143.
      Citations:    Fields:    Translation:Humans
    3. Hlubocky FJ, Symington BE, McFarland DC, Gallagher CM, Dragnev KH, Burke JM, Lee RT, El-Jawahri A, Popp B, Rosenberg AR, Thompson MA, Dizon DS, Srivastava P, Patel MI, Kamal AH, Daugherty CK, Back AL, Dokucu ME, Shanafelt TD. Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience. JCO Oncol Pract. 2021 07; 17(7):365-374. PMID: 33555934.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    4. Hlubocky FJ, Sher TG, Cella D, Wroblewski KE, Peppercorn J, Daugherty CK. Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers. JCO Oncol Pract. 2021 02; 17(2):e101-e110. PMID: 33567241; PMCID: PMC8258142.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Hantel A, Hlubocky FJ, Siegler M, Daugherty CK. A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed. JCO Oncol Pract. 2020 10; 16(10):e1098-e1111. PMID: 32469685.
      Citations:    Fields:    Translation:Humans
    6. Temel JS, Sloan J, Zemla T, Greer JA, Jackson VA, El-Jawahri A, Kamdar M, Kamal A, Blinderman CD, Strand J, Zylla D, Daugherty C, Furqan M, Obel J, Razaq M, Roeland EJ, Loprinzi C. Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. J Palliat Med. 2020 07; 23(7):922-929. PMID: 32031887; PMCID: PMC7307668.
      Citations: 11     Fields:    Translation:Humans
    7. Hantel A, Egan AM, Nguyen TT, DeMartino ES, Hlubocky F, Bastow S, Siegler M, Daugherty CK. A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages. J Grad Med Educ. 2020 Feb; 12(1):38-43. PMID: 32089792; PMCID: PMC7012528.
      Citations: 1     Fields:    Translation:Humans
    8. Strohbehn GW, Daugherty CK. Mistaking the Trees for the Forest? Oncologist. 2020 04; 25(4):e743. PMID: 31873980; PMCID: PMC7160407.
      Citations:    Fields:    Translation:Humans
    9. Garrett SB, Matthews TM, Abramson CM, Koenig CJ, Hlubocky FJ, Daugherty CK, Munster PN, Dohan D. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials. JCO Oncol Pract. 2020 01; 16(1):e56-e63. PMID: 31603726; PMCID: PMC6993554.
      Citations: 1     Fields:    Translation:Humans
    10. Hantel A, Siegler M, Hlubocky F, Colgan K, Daugherty CK. Prevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists. JAMA Intern Med. 2019 05 01; 179(5):710-711. PMID: 30907925; PMCID: PMC6503559.
      Citations: 9     Fields:    Translation:Humans
    11. Hlubocky FJ, Daugherty CK. Reply to J. Schildmann et al. J Clin Oncol. 2019 01 10; 37(2):170-171. PMID: 30433849.
      Citations:    Fields:    Translation:Humans
    12. Hlubocky FJ, Sachs GA, Larson ER, Nimeiri HS, Cella D, Wroblewski KE, Ratain MJ, Peppercorn JM, Daugherty CK. Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials? J Clin Oncol. 2018 08 20; 36(24):2483-2491. PMID: 29985748; PMCID: PMC6097830.
      Citations: 6     Fields:    Translation:Humans
    13. Hlubocky FJ, Kass NE, Roter D, Larson S, Wroblewski KE, Sugarman J, Daugherty CK. Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials. J Oncol Pract. 2018 06; 14(6):e357-e367. PMID: 29787333; PMCID: PMC6002254.
      Citations: 6     Fields:    Translation:Humans
    14. Drazer MW, Kadri S, Sukhanova M, Patil SA, West AH, Feurstein S, Calderon DA, Jones MF, Weipert CM, Daugherty CK, Raca G, Lingen MW, Li Z, Segal JP, Churpek JE, Godley LA, Ceballos-López AA. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Adv. 2018 01 23; 2(2):146-150. PMID: 29365323; PMCID: PMC5787862.
      Citations: 38     Fields:    Translation:HumansCells
    15. Garrett SB, Koenig CJ, Trupin L, Hlubocky FJ, Daugherty CK, Reinert A, Munster P, Dohan D. What advanced cancer patients with limited treatment options know about clinical research: a qualitative study. Support Care Cancer. 2017 10; 25(10):3235-3242. PMID: 28488050; PMCID: PMC5680157.
      Citations: 9     Fields:    Translation:Humans
    16. de Souza JA, Yap BJ, Wroblewski K, Blinder V, Hlubocky FJ, Nicholas LH, O'Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella D, Araújo FS. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017 02 01; 123(3):476-484. PMID: 27716900; PMCID: PMC5298039.
      Citations: 263     Fields:    Translation:Humans
    17. Dunn LB, Wiley J, Garrett S, Hlubocky F, Daugherty C, Trupin L, Munster P, Dohan D. Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients. Psychooncology. 2017 Oct; 26(10):1604-1610. PMID: 27233054.
      Citations: 5     Fields:    Translation:Humans
    18. Polite BN, Cipriano-Steffens T, Hlubocky F, Dignam J, Ray M, Smith D, Undevia S, Sprague E, Olopade O, Daugherty C, Fitchett G, Gehlert S. An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population. J Racial Ethn Health Disparities. 2017 04; 4(2):140-148. PMID: 26983622.
      Citations: 2     Fields:    Translation:Humans
    19. Muffly LS, Hlubocky FJ, Khan N, Wroblewski K, Breitenbach K, Gomez J, McNeer JL, Stock W, Daugherty CK. Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 2016 Mar 15; 122(6):954-61. PMID: 26749023.
      Citations: 19     Fields:    Translation:Humans
    20. Rao VL, Daugherty C. Is it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe? Clin Liver Dis (Hoboken). 2015 Nov; 6(5):120-121. PMID: 31041005; PMCID: PMC6490669.
    21. de Souza JA, Yap B, Ratain MJ, Daugherty C. User beware: we need more science and less art when measuring financial toxicity in oncology. J Clin Oncol. 2015 Apr 20; 33(12):1414-5. PMID: 25732158.
      Citations: 7     Fields:    Translation:Humans
    22. de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty CK. The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer. 2014 Oct 15; 120(20):3245-53. PMID: 24954526.
      Citations: 209     Fields:    Translation:Humans
    23. Harris D, Patrick-Miller L, Schwartz L, Lantos J, Daugherty C, Daly M, Andrulis IL, Buys SS, Chung WK, Frost CJ, John EM, Keegan TH, Knight JA, Terry MB, Bradbury AR. Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families. J Adolesc Health. 2014 Sep; 55(3):352-7. PMID: 24845866; PMCID: PMC4234071.
      Citations: 4     Fields:    Translation:Humans
    24. Suh E, Daugherty CK, Wroblewski K, Lee H, Kigin ML, Rasinski KA, Ford JS, Tonorezos ES, Nathan PC, Oeffinger KC, Henderson TO. General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014 Jan 07; 160(1):11-7. PMID: 24573662; PMCID: PMC4337806.
      Citations: 87     Fields:    Translation:Humans
    25. Nathan PC, Daugherty CK, Wroblewski KE, Kigin ML, Stewart TV, Hlubocky FJ, Grunfeld E, Del Giudice ME, Ward LA, Galliher JM, Oeffinger KC, Henderson TO. Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2013 Sep; 7(3):275-82. PMID: 23471729.
      Citations: 86     Fields:    Translation:Humans
    26. Ishida Y, Takahashi M, Maru M, Mori M, Henderson TO, Daugherty CK, Manabe A. Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology. Jpn J Clin Oncol. 2012 Jun; 42(6):513-21. PMID: 22457322.
      Citations: 5     Fields:    Translation:Humans
    27. Larson SM, Campbell NP, Huo D, Artz A, Zhang Y, Gajria D, Green M, Weiner H, Daugherty C, Odenike O, Godley LA, Hyjek E, Gurbuxani S, Thirman M, Sipkins D, Van Besien K, Larson RA, Stock W. High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leuk Lymphoma. 2012 Mar; 53(3):445-50. PMID: 21913806.
      Citations: 7     Fields:    Translation:Humans
    28. Spill GR, Hlubocky FJ, Daugherty CK. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer. PM R. 2012 Feb; 4(2):96-108. PMID: 22373458.
      Citations: 10     Fields:    Translation:Humans
    29. Bradbury AR, Patrick-Miller L, Egleston BL, Olopade OI, Daly MB, Moore CW, Sands CB, Schmidheiser H, Kondamudi PK, Feigon M, Ibe CN, Daugherty CK. When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response. Cancer. 2012 Jul 01; 118(13):3417-25. PMID: 22231763; PMCID: PMC3326182.
      Citations: 28     Fields:    Translation:Humans
    30. Zafar SY, Currow DC, Daugherty CK, Abernethy AP. Standards for palliative care delivery in oncology settings. Cancer J. 2010 Sep-Oct; 16(5):436-43. PMID: 20890139.
      Citations: 3     Fields:    Translation:Humans
    31. Bradbury AR, Patrick-Miller L, Egleston B, Sands CB, Li T, Schmidheiser H, Feigon M, Ibe CN, Hlubocky FJ, Hope K, Jackson S, Corbman M, Olopade OI, Daly M, Daugherty CK. Parent opinions regarding the genetic testing of minors for BRCA1/2. J Clin Oncol. 2010 Jul 20; 28(21):3498-505. PMID: 20567018.
      Citations: 10     Fields:    Translation:Humans
    32. Godley LA, Njiaju UO, Green M, Weiner H, Lin S, Odenike O, Rich ES, Artz A, Van Besien K, Daugherty CK, Zhang Y, Le Beau MM, Stock W, Larson RA. Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant. Leuk Lymphoma. 2010 Jun; 51(6):995-1006. PMID: 20536346.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    33. Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CK. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. J Clin Oncol. 2010 Feb 10; 28(5):878-83. PMID: 20038717; PMCID: PMC3040043.
      Citations: 39     Fields:    Translation:Humans
    34. Kass NE, Sugarman J, Medley AM, Fogarty LA, Taylor HA, Daugherty CK, Emerson MR, Goodman SN, Hlubocky FJ, Hurwitz HI, Carducci M, Goodwin-Landher A. An intervention to improve cancer patients' understanding of early-phase clinical trials. IRB. 2009 May-Jun; 31(3):1-10. PMID: 19552233; PMCID: PMC2872090.
      Citations: 38     Fields:    Translation:Humans
    35. Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Hlubocky F, Olopade OI, Daugherty CK. Learning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences. Psychooncology. 2009 Feb; 18(2):200-8. PMID: 18702049; PMCID: PMC4535792.
      Citations: 29     Fields:    Translation:Humans
    36. Daugherty CK, Hlubocky FJ. What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure. J Clin Oncol. 2008 Dec 20; 26(36):5988-93. PMID: 19029419; PMCID: PMC2645114.
      Citations: 49     Fields:    Translation:Humans
    37. Lee RT, Hlubocky FJ, Hu JJ, Stafford RS, Daugherty CK. An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM). Integr Cancer Ther. 2008 Jun; 7(2):70-5. PMID: 18505899.
      Citations: 19     Fields:    Translation:Humans
    38. Bradbury AR, Patrick-Miller L, Feigon M, Pawlowski K, Egleston B, Ibe C, Sands CB, Cummings S, Olopade OI, Daugherty CK. Should genetic testing for BRCA1/2 be permitted for minors? Opinions of parents who completed BRCA1/2 testing. J Clin Oncol. 2008 May 20; 26(15_suppl):1511. PMID: 27948352.
    39. Hlubocky FJ, Larson E, Sachs G, Lesniak MS, Ratain MJ, Daugherty CK. A study of informed consent (IC), age, and cognitive performance (CP) among advanced cancer patients (acp) in phase I trials. J Clin Oncol. 2008 May 20; 26(15_suppl):9523. PMID: 27948232.
    40. Daugherty CK, Spill G, Siegler M, Hlubocky FJ. Oncologists and physiatrists attitudes regarding rehabilitation for patients with advanced cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6623. PMID: 27949371.
    41. Harding GA, Hlubocky FJ, Siegler M, Daugherty CK. Canadian oncologist communication about prognosis disclosure with their terminally-ill patients. J Clin Oncol. 2008 May 20; 26(15_suppl):6554. PMID: 27949814.
    42. Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Olopade OI, Daugherty CK. Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. Am J Med Genet C Semin Med Genet. 2008 Feb 15; 148C(1):70-7. PMID: 18200524.
      Citations: 11     Fields:    Translation:Humans
    43. Daugherty CK, Ratain MJ, Emanuel EJ, Farrell AT, Schilsky RL. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol. 2008 Mar 10; 26(8):1371-8. PMID: 18227527.
      Citations: 16     Fields:    Translation:Humans
    44. Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM, Rich E, Smith SM, Zimmerman T, Zhang Y, Huo D, Larson R, van Besien K. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2007 Dec; 40(11):1027-32. PMID: 17846595.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    45. Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol. 2007 Aug 20; 25(24):3705-11. PMID: 17704419.
      Citations: 43     Fields:    Translation:Humans
    46. Gray SW, Hlubocky FJ, Ratain MJ, Daugherty CK. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. J Clin Oncol. 2007 Aug 10; 25(23):3488-94. PMID: 17687154.
      Citations: 9     Fields:    Translation:Humans
    47. Vohra PD, Johnson JK, Daugherty CK, Wen M, Barach P. Housestaff and medical student attitudes toward medical errors and adverse events. Jt Comm J Qual Patient Saf. 2007 Aug; 33(8):493-501. PMID: 17724946.
      Citations: 12     Fields:    Translation:Humans
    48. Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007 Feb 10; 25(5):548-54. PMID: 17290064.
      Citations: 36     Fields:    Translation:Humans
    49. Helft PR, Daugherty CK. Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. J Clin Oncol. 2006 Oct 20; 24(30):4793-5. PMID: 17050863.
      Citations: 24     Fields:    Translation:Humans
    50. Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O, Zimmerman T, Smith S, Godley L, Thirman M, Daugherty C, Extermann M, Larson R, van Besien K. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006 Sep; 12(9):954-64. PMID: 16920562.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    51. Helft PR, Eckles RE, Johnson-Calley CS, Daugherty CK. Use of the internet to obtain cancer information among cancer patients at an urban county hospital. J Clin Oncol. 2005 Aug 01; 23(22):4954-62. PMID: 16051948.
      Citations: 33     Fields:    Translation:Humans
    52. van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L, Jones D, Del Cerro P, Bennett D, Casey B, Odenike O, Thirman M, Daugherty C, Wickrema A, Zimmerman T, Larson RA, Stock W. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38. PMID: 16009946.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    53. Bradbury AR, Daugherty CK, Auh S, Hlubocky FJ, Cummings S, White M, Olopade OI. Parental disclosure of genetic test results to young adults, adolescents and children. J Clin Oncol. 2005 Jun; 23(16_suppl):1016. PMID: 27944904.
    54. Hlubocky FJ, Helft PR, Daugherty CK. Hope, decision making, and use of the internet and other media among cancer clinical trials participants. J Clin Oncol. 2005 Jun; 23(16_suppl):6068. PMID: 27945918.
    55. Teitelbaum UR, Hlubocky FJ, Daugherty CK. Survival and informed consent understanding of elderly advanced cancer patients enrolling in phase I trials. J Clin Oncol. 2005 Jun; 23(16_suppl):8109. PMID: 27947041.
    56. Daugherty CK, Fitchett G, Murphy PE, Peterman AH, Banik DM, Hlubocky F, Tartaro J. Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psychooncology. 2005 Feb; 14(2):135-46. PMID: 15386780.
      Citations: 19     Fields:    Translation:Humans
    57. Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RA. A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer Chemother Pharmacol. 2004 Dec; 54(6):553-61. PMID: 15349753.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    58. Daugherty CK. Ethical issues in phase I clinical trials. Clin Adv Hematol Oncol. 2004 Jun; 2(6):358-60. PMID: 16163205.
      Citations:    Fields:    Translation:Humans
    59. Daugherty CK. Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Invest. 2004; 22(1):123-31. PMID: 15069770.
      Citations: 6     Fields:    Translation:Humans
    60. Helft PR, Hlubocky F, Wen M, Daugherty CK. Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials. Support Care Cancer. 2003 Oct; 11(10):644-51. PMID: 12883963.
      Citations: 13     Fields:    Translation:Humans
    61. Daugherty CK, Steensma DP. Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2003 May 01; 21(9 Suppl):42s-45s. PMID: 12743190.
      Citations: 5     Fields:    Translation:Humans
    62. Gordon EJ, Daugherty CK. 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003 Apr; 17(2):142-68. PMID: 12812182.
      Citations: 62     Fields:    Translation:Humans
    63. Helft PR, Hlubocky F, Daugherty CK. American oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members. J Clin Oncol. 2003 Mar 01; 21(5):942-7. PMID: 12610198.
      Citations: 61     Fields:    Translation:Humans
    64. Daugherty CK. The "cure" for cancer: can the media report the hope without the hype? J Clin Oncol. 2002 Sep 15; 20(18):3761-4. PMID: 12228195.
      Citations:    Fields:    Translation:Humans
    65. Daugherty CK, Steensma DP. Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2002 Jun 01; 20(11):2752-5. PMID: 12039940.
      Citations: 5     Fields:    Translation:Humans
    66. Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K, Larson RA. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001 Jun; 27(11):1181-8. PMID: 11551029.
      Citations: 17     Fields:    Translation:Humans
    67. Cataland SR, Daugherty CK, Weseman EC, Larson RA, Cataland SR, Daugherty CK, Weseman EC, Larson RA. Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2001 Apr; 41(3-4):297-307. PMID: 11378542.
      Citations: 3     Fields:    Translation:Humans
    68. Gordon EJ, Daugherty CK. Referral and decision making among advanced cancer patients participating in Phase I trials at a single institution. J Clin Ethics. 2001; 12(1):31-8. PMID: 11428154.
      Citations: 2     Fields:    Translation:Humans
    69. Daugherty CK, Banik DM, Janish L, Ratain MJ. Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. IRB. 2000 May-Jun; 22(3):6-14. PMID: 11697385.
      Citations: 41     Fields:    Translation:Humans
    70. Sobecks RM, Daugherty CK, Hallahan DE, Laport GF, Wagner ND, Larson RA. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies. Bone Marrow Transplant. 2000 Apr; 25(8):807-13. PMID: 10808200.
      Citations: 10     Fields:    Translation:HumansCells
    71. Daugherty CK. Informed consent, the cancer patient, and phase I clinical trials. Cancer Treat Res. 2000; 102:77-89. PMID: 10650482.
      Citations: 2     Fields:    Translation:Humans
    72. Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999 May; 17(5):1601-17. PMID: 10334550.
      Citations: 23     Fields:    Translation:Humans
    73. Daugherty CK. Ethical issues in the development of new agents. Invest New Drugs. 1999; 17(2):145-53. PMID: 10638485.
      Citations: 4     Fields:    Translation:Humans
    74. Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab. 1998 Aug; 83(8):2717-25. PMID: 9709937.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    75. Daugherty CK, Ratain MJ, Minami H, Banik DM, Vogelzang NJ, Stadler WM, Siegler M. Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol. 1998 Jul; 16(7):2305-12. PMID: 9667244.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    76. Dann EJ, Daugherty CK, Larson RA. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997 Sep; 20(5):369-74. PMID: 9339751.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    77. Daugherty CK, Siegler M, Ratain MJ, Zimmer G. Learning from our patients: one participant's impact on clinical trial research and informed consent. Ann Intern Med. 1997 Jun 01; 126(11):892-7. PMID: 9163291.
      Citations: 3     Fields:    Translation:Humans
    78. Daugherty CK, Geller G. Hope and the limits of research. Hastings Cent Rep. 1996 Sep-Oct; 26(5):20; discussion 20-2. PMID: 8891704.
      Citations:    Fields:    Translation:Humans
    79. Sharma L, Sinacore J, Daugherty C, Kuesis DT, Stulberg SD, Lewis M, Baumann G, Chang RW. Prognostic factors for functional outcome of total knee replacement: a prospective study. J Gerontol A Biol Sci Med Sci. 1996 Jul; 51(4):M152-7. PMID: 8680997.
      Citations: 23     Fields:    Translation:Humans
    80. Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler M. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995 May; 13(5):1062-72. PMID: 7738612.
      Citations: 141     Fields:    Translation:Humans
    81. Daugherty CK, Ratain MJ, Siegler M. Pushing the envelope: informed consent in phase I trials. Ann Oncol. 1995 Apr; 6(4):321-3. PMID: 7619746.
      Citations: 3     Fields:    Translation:Humans
    82. Mick R, Lane N, Daugherty C, Ratain MJ. Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials. J Natl Cancer Inst. 1994 Nov 16; 86(22):1685-93. PMID: 7966396.
      Citations: 3     Fields:    Translation:Humans
    83. FitzGerald TJ, McKenna M, Kase K, Daugherty C, Rothstein L, Greenberger JS. Effect of X-irradiation dose rate on the clonagenic survival of human and experimental animal hematopoietic tumor cell lines: evidence for heterogeneity. Int J Radiat Oncol Biol Phys. 1986 Jan; 12(1):69-73. PMID: 3943994.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    84. Greenberger JS, Palaszynski EW, Pierce JH, Sakakeeny MA, Ruscetti SK, Ihle JN, Daugherty C. Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines. J Natl Cancer Inst. 1985 Jan; 74(1):247-62. PMID: 3918212.
      Citations: 4     Fields:    Translation:AnimalsCells
    Daugherty's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (345)
    Co-Authors (37)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors